Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease
- 1 October 2018
- journal article
- research article
- Published by Springer Nature in Pharmacological Reports
- Vol. 70 (5) , 988-992
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative process leading to the loss of dopaminergic neurons and their projections. 1-methyl-4-phenol-1,2,5,6-tetrahydropyridine (MPTP) toxicity is a well-recognized animal model of PD. It is suggested that the impairment of mitochondrial function in the substantia nigra plays an important role in both the onset and the progression of PD. Octanoic acid (C8), a fatty acid that is the main constituent of the medium-chain triglyceride ketogenic diet, increases the metabolic activity of mitochondria; hence, it seemed interesting to investigate whether C8 exhibits neuroprotective effects in the MPTP model of PD and whether it affects mitochondria function in the striatum. Therefore, we examined the possible protective effects of C8 in the mouse model of PD induced by MPTP. For this purpose, changes in the concentration of DA and its metabolites were determined. In addition, we investigated whether expression levels of PGC-1α and the PEPCK enzyme, markers of mitochondrial activity, are altered by C8. In this study, we observed for the first time that acute and, in particular, repeated administrations of C8 significantly reduced the impairment of dopaminergic neurotransmission in the striatum evoked by MPTP administration and resulted in a marked increase in PGC-1α expression and in both forms of PEPCK. These results indicate that the C8 leads to an inhibition of the neurodegenerative processes seen after MPTP administration. Our results suggest that a probable mechanism of the neuroprotective action of C8 is related to an increase in metabolic activity in striatal mitochondria.Keywords
Funding Information
- National Science Centre, Kraków, Poland (NCN 2016/21/B/NZ7/02066)
- European Union‐The European Regional Development Fund
This publication has 13 references indexed in Scilit:
- Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishmentBrain, 2015
- Unravelling mitochondrial pathways to Parkinson's diseaseBritish Journal of Pharmacology, 2014
- Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS DiseasePLOS ONE, 2012
- Pgc-1α Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated with Decreased BdnfPLOS ONE, 2012
- PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseScience Translational Medicine, 2010
- Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's diseaseBrain Research, 2009
- Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineBrain Research, 2009
- Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional CoactivatorsCell, 2006
- Parkinson's DiseaseNeuron, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001